The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

PHAT FINANCIAL STATEMENTS

Phathom Pharmaceuticals Inc — balance sheet, income statement and cash flow trends

PHATPhathom Pharmaceuticals Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-200 M0200 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue239.7 M $Gross Profit198.7 M $ · 83%Operating Income-40.6 M $ · -17%Pre-tax Income-81.5 M $ · -34%Net Income to Owners-81.5 M $ · -34%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue239.7 M $+110.2%
Gross Profit198.7 M $+100.5%
Operating Income-40.6 M $—
EBITDA-36.7 M $—
Net Income to Owners-81.5 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0500 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets327.1 M
  • Current Liabilities153.8 M $23%
  • Long-term Liabilities517.6 M $77%

Key Figures

YoY change
Total Assets327.1 M $+30.7%
Total Liabilities671.3 M $+2.3%
Total Equity-344.3 M $—
Cash & ST Investments182.5 M $+22.0%
Total Debt2.5 M $-99.6%
Net Debt-180 M $-142.3%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-200 M-100 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-40 M-20 M020 M-36.7 M $Operating-219 K $Investing69.8 M $Financing32.9 M $Net Change

Key Figures

YoY change
Operating Cash Flow-36.7 M $—
Capital Expenditures264 K $+28.2%
Free Cash Flow-36.5 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on PHAT

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.